Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Allegion (ALLE) Q3 Earnings And Revenues Beat Estimates

Published 10/23/2019, 10:23 PM
Updated 07/09/2023, 06:31 AM

Allegion plc (NYSE:ALLE) reported better-than-expected results for third-quarter 2019, wherein both adjusted earnings and revenues beat the Zacks Consensus Estimate.

Earnings/Revenues

Quarterly adjusted earnings came in at $1.47 per share, surpassing the Zacks Consensus Estimate of $1.33. Moreover, the bottom line was 19.5% higher than the year-ago figure. The upside can be primarily attributed to solid sales growth and improved operating income.

Allegion PLC Price, Consensus and EPS Surprise

Allegion PLC price-consensus-eps-surprise-chart | Allegion PLC Quote

Revenues came in at $748.3 million, up 5.2% year over year. In addition, the top line beat the consensus estimate of $739 million. Revenues jumped 6.4% on an organic basis. The rise was backed by strength in Americas non-residential and residential businesses and strong pricing benefits, partially offset by adverse impact of unfavorable foreign exchange movements.

Revenues in the Americas rose 7.1% year over year to $567.8 million. EMEIA (Europe, Middle East, India and Africa) revenues increased 2.5% to $137.8 million. Revenues in Asia-Pacific fell 9.1% to $42.7 million in the reported quarter.

Costs/Margins

In the third quarter, Allegion’s cost of sales jumped 2.7% year over year to $412.8 million. Gross profit grew 8.4% to $335.5 million while gross margin improved 130 basis points (bps) to 44.8%.

Selling and administrative expenses increased 0.2% year over year to $167.4 million.

Adjusted operating margin expanded 220 bps to 23.1%.

Balance Sheet/Cash Flow

As of Sep 30, 2019, Allegion had cash and cash equivalents of $232.9 million, down from $283.8 recorded on Dec 31, 2018. Long-term debt was $1,427 million, up from $1,409.5 million recorded at the end of 2018.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In the first nine months of 2019, the company generated net cash of $279.4 million from operating activities, up 7.3% from the year-ago period. Capital expenditures totaled $49.4 million compared with $31.8 million a year ago.
2019 Guidance

Adjusted earnings per share are now expected in the range of $4.85 to $4.90 compared with $4.80-$4.90 guided earlier.

The company expects full-year 2019 revenue growth on both reported and organic basis in the band of 4.5-5.5%.

Full-year adjusted effective tax rate is anticipated to be 15.5%.

Available cash flow is targeted to be approximately $410-$430 million.

Zacks Rank & Key Picks

Allegion currently carries a Zacks Rank #4 (Sell).

Some better-ranked stocks in the same space are Cimpress N.V (NASDAQ:CMPR) , Brady Corporation (NYSE:BRC) and Dover Corporation (NYSE:DOV) . While Cimpress sports a Zacks Rank #1 (Strong Buy), Brady and Dover carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Cimpress’ earnings surprise in the last reported quarter was a positive 137.04%.

Brady delivered average positive earnings surprise of 9.68% in the trailing four quarters.

Dover pulled off average positive earnings surprise of 6.70% in the trailing four quarters.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

See their latest picks free >>



Dover Corporation (DOV): Free Stock Analysis Report

Cimpress N.V (CMPR): Free Stock Analysis Report

Allegion PLC (ALLE): Free Stock Analysis Report

Brady Corporation (BRC): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.